06:04 EDT Portage Biotech (PRTG) files $40M mixed securities shelf
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRTG:
- Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma
- Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study
- Portage Biotech trading resumes
- Portage Biotech trading halted, volatility trading pause
- Portage Biotech Announces Promising Preclinical Results for PORT-7 in Mesothelioma